Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Clinical trial NCT05304481 · RECRUITING
Trial details
- NCT number
- NCT05304481
- Sponsor
- Lukas Biomedical Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-14
- Primary completion
- 2026-12-31
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.